PAB 0.00% 0.3¢ patrys limited

Ann: Patrys Reports Progress on Preclinical Programmes, page-37

  1. 3,884 Posts.
    lightbulb Created with Sketch. 437
    What do people make of the move from the PER.C6 cell line to the CHO method?

    Does this throw negative light back on Patrys ability to produce at scale using their own methods or does it show that large pharma is serious about the drug and wants to know if it can produce it with their preferred method?

    I think this is a major announcement and fundamental change to the company.
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $6.172M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $303 105K

Buyers (Bids)

No. Vol. Price($)
22 31260978 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 8671441 9
View Market Depth
Last trade - 16.10pm 31/01/2025 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.